Author

A. Lachmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ma'ayan· 1 shared B. Lee· 1 shared B. R. tenOever· 1 shared C. Stevens· 1 shared D. A. Hoagland· 1 shared D. J. B. Clarke· 1 shared K. Y. Oguntuyo· 1 shared L. Yang· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ma'ayan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds

D. A. Hoagland, D. J. B. Clarke, R. Moeller, Y. Han, L. Yang, M. L. Wojciechowicz, A. Lachmann, K. Y. Oguntuyo, C. Stevens, B. Lee, S. Chen, A. Ma'ayan, B. R. tenOever

This study identifies antiviral compounds that reduce SARS-CoV-2 viral load by counteracting the virus-induced transcriptional landscape, without affecting viral entry or host antiviral response.

bioRxiv · Jul 12, 2020 · PreprintMicrobiology